ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,374, issued on March 18, was assigned to LTS Lohmann Therapie-Systeme AG (Andernach, Germany).
"Fampridine TTS" was invented by Rosemarie Keikert (Andernach, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a transdermal therapeutic system for cutaneous administration of fampridine. The system includes an active ingredient-impermeable backing layer, a pressure-sensitive adhesive reservoir layer and optionally a detachable protective layer. The pressure-sensitive adhesive reservoir layer is formed from fampridine and at least one matrix polymer containing no free carboxylic acid and/or carboxylate groups, with ...